The low-risk score was accompanied with up-regulation of circadian clock and JNK-MAPK pathway (Figure 8A and 8B) (Supplementary File S2), both of which have inhibitory effects on the growth of lung cancer [40, 41]. The gene discussed is CLOCK; the disease is lung cancer.